logo

Zenas Biopharma Inc (ZBIO) Stock: Navigating a Year of Stock Volatility

THMO

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Zenas Biopharma Inc’s current trading price is -63.89% away from its 52-week high, while its distance from the 52-week low is 10.23%. The stock’s price range during this period has varied between $8.60 and $26.25. The company, active in the Healthcare sector, saw a trading volume of around 0.71 million for the day, considerably higher average daily volume of 0.21 million observed over the last three months.

How Financial Performance Impacts Market Capitalization

Zenas Biopharma Inc (ZBIO) has experienced a quarterly decline of -47.04% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 396.18M.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The Role of Moving Averages and Trading Volume in Technical Analysis

How ZBIO’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for ZBIO stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.

ZBIO Stock Stochastic Average

As of today, the raw stochastic average of Zenas Biopharma Inc over the past 50 days is 6.42%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 16.99%. Additionally, the Stochastic %K and %D values for the company were 6.62% and 3.58%, respectively, over the past 20 days.

ZBIO Stock Price Performance Analysis

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. This year’s metric has recorded a Price decrease of -47.77%. The price of ZBIO leaped by -44.59% over the last 30 days. And in the last five days, it has fallen by -0.21%.

Most Popular